Early suppression of the serological macrophage activity biomarker VICM, and not suppression of CRP, predicts the response to infliximab in Crohn's disease patients

J. H. Mortensen; W. T. van Haaften; M. L. Olesen; M. Karsdal; P. Olinga; G. Dijkstra; A. -C. Bay-Jensen

Early suppression of the serological macrophage activity biomarker VICM, and not suppression of CRP, predicts the response to infliximab in Crohn's disease patients

J. H. Mortensen, W. T. van Haaften, M. L. Olesen, M. Karsdal, P. Olinga, G. Dijkstra, A. -C. Bay-Jensen

Onderzoeksoutput: Meeting Abstract › Academic

Originele taal-2	English
Pagina's (van-tot)	S423-S424
Aantal pagina's	2
Tijdschrift	Journal of Crohn's and Colitis
Volume	11
Status	Published - 1-feb.-2017

Handle.net

Permanente koppeling

Citeer dit

@article{665d99dbcc354dd6ad8fec0be27d8d2b,

title = "Early suppression of the serological macrophage activity biomarker VICM, and not suppression of CRP, predicts the response to infliximab in Crohn's disease patients",

author = "Mortensen, {J. H.} and {van Haaften}, {W. T.} and Olesen, {M. L.} and M. Karsdal and P. Olinga and G. Dijkstra and Bay-Jensen, {A. -C.}",

year = "2017",

month = feb,

day = "1",

language = "English",

volume = "11",

pages = "S423--S424",

journal = "Journal of Crohn's and Colitis",

issn = "1873-9946",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Early suppression of the serological macrophage activity biomarker VICM, and not suppression of CRP, predicts the response to infliximab in Crohn's disease patients

AU - Mortensen, J. H.

AU - van Haaften, W. T.

AU - Olesen, M. L.

AU - Karsdal, M.

AU - Olinga, P.

AU - Dijkstra, G.

AU - Bay-Jensen, A. -C.

PY - 2017/2/1

Y1 - 2017/2/1

M3 - Meeting Abstract

SN - 1873-9946

VL - 11

SP - S423-S424

JO - Journal of Crohn's and Colitis

JF - Journal of Crohn's and Colitis

ER -